Calidi Biotherapeutics Inc (CLDI)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Calidi Biotherapeutics Inc

Healthcare (1087)

Biotechnology (606)

(858) 794-9600

4475 Executive Drive, Suite 200, San Diego

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CLDI's Discussions on Twitter

Compare CLDI vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CLDI Calidi Biotherapeutics Inc	1.33	3.49M	0	-25.09M	-18.40M	-5.1824
VRTX Vertex Pharmaceuticals Inc	522.83	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	800.17	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,000.20	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.32	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.18	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-11-22	Eingeleitet	H.C. Wainwright	Buy
2023-10-09	Eingeleitet	Robert W. Baird	Outperform

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)

Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Compare CLDI vs VRTX, REGN, ARGX, MRNA, RVMD

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire

Calidi Biotherapeutics Inc. (NYSE: CLDI) Share Price, CLDI Stock News, CLDI Share Price & Updates - Kalkine

CLDI Q4 2025 Earnings: Loss Narrows Sharply, Beating Estimates by 73.59%; Shares Rise 3.41%Dividend Earnings Report - vinanet.vn

ARMISTICE CAPITAL, LLC Slashes Calidi Biotherapeutics (CLDI) Sta - GuruFocus

Calidi (CLDI) Quarterly Scorecard: EPS Exceeds Its Estimate in Latest Trading; Market Response: Shares Move Lower 2.90%Dividend Cut Risk - vinanet.vn

Calidi Biotherapeutics (CLDI) grants director 5,000 options - Stock Titan

Calidi director granted 4,000 options at $1.36 | CLDI Insider Trading - Stock Titan

Calidi Biotherapeutics (CLDI) gives CFO 14,000 options with 10-year term - Stock Titan

Calidi Biotherapeutics (CLDI) awards director 4,000 options vesting in 1 year - Stock Titan

Calidi Biotherapeutics (CLDI) CEO awarded 32K options vesting over 4 years - Stock Titan

Calidi (CLDI) Report Card: The EPS Result Is Above Expectation in the Current Update; Reaction Snapshot: Shares Close 6.62% Lower in the Latest SessionTrough Earnings Signal - vinanet.vn

Calidi (CLDI) Closing Snapshot: Retreats 5.59% to $1.28 in the Current Update; Technical Position: the Near-Term Reference Band Stretches From $1.22 to $1.34 on the DayCalendar Spread Trade - vinanet.vn

Calidi Biotherapeutics Granted Patent for Cell-Based Oncolytic Virus Immunotherapy for Cancer Treatment - ACCESS Newswire

Armistice Capital reports 4.99% Calidi Biotherapeutics (CLDI) stake in Schedule 13G/A - Stock Titan

Calidi Biotherapeutics Inc (CLDI) Valuation: PE, PB & Fair Value Analysis - TradingKey

Form 8K Calidi Biotherapeutics Inc For: 13 August By Investing.com - Investing.com Nigeria

Calidi Biotherapeutics Reports Quarterly Results and Pipeline Progress - TipRanks

Calidi Biotherapeutics Q2 net loss narrows to $4.2M; G&A cuts 48% - scanx.trade

Calidi Biotherapeutics 2Q 2026: Net loss $4.16M, EPS $(2.94) — 10-Q Summary - TradingView

Calidi Biotherapeutics Reports Positive FDA Pre-IND Feedback for CLD-401, Showcases RedTail Platform Data and Cuts G&A Expenses - Quiver Quantitative

Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Yahoo Finance

Price to book forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView

Price to sales forward of Calidi Biotherapeutics Inc. – OTC:CLDWW - TradingView

Calidi Biotherapeutics Inc (CLDI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Calidi Biotherapeutics (CLDI) Holds Steady at $1.63 as Stock Sits Between Support and ResistanceEntry Point Alerts - dars.gov.et

CLDI Q4 2025 Earnings: Narrower Loss of -$0.43 Per Share Beats Estimates, Stock Falls 9.5%High Estimate Range - vinanet.vn

Calidi Biotherapeutics (CLDI) Insider Trading Activity 2026 $CLDI - MarketBeat

Calidi Biotherapeutics (CLDI) Falls 6.88% to $1.76, Pressing Key Support at $1.67MACD Signal Stocks - dars.gov.et

Calidi Biotherapeutics (CLDI) Jumps 12.5% to $1.89 as Bullish Momentum Builds Toward $1.98 ResistanceSector Neutral Pair - vinanet.vn

Price to sales forward of Calidi Biotherapeutics, Inc. – BOATS:CLDI - TradingView

Calidi Biotherapeutics (CLDI) Surges 9.86% to $1.64 as Buying Pressure BuildsGolden Cross - vinanet.vn

Calidi Biotherapeutics Announces Reverse Stock Split to Maintain NYSE American Listing – July 2026 8-K Filing - Minichart

Calidi Biotherapeutics Implements Reverse Stock Split on NYSE - TipRanks

Price to book forward of Calidi Biotherapeutics, Inc. – AMEX:CLDI - TradingView

Calidi Biotherapeutics Inc (CLDI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

CLDI|Calidi Biotherapeutics Inc|Price:0.109|Chg%:+0.009 - TradingKey

Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference - GlobeNewswire

Calidi Biotherapeutics Inc (CLDI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Calidi highlights new EpCam-targeting T-cell engager data - Stock Titan

Calidi Biotherapeutics Inc (CLDI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Calidi Biotherapeutics Inc (CLDI) Cash Flow - TradingKey

Stock Splits Calendar for: - Yahoo! Finance Canada

TradingKey - TradingKey

CLDI Q4 2025 Earnings: Smaller-Than-Expected Loss Fails to Lift SharesGrowth Acceleration Report - vinanet.vn

Calidi Biotherapeutics Inc (CLDI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Calidi Biotherapeutics (CLDI) Holds at $0.1 Support After Minor DeclinePut Support - vinanet.vn

Calidi Biotherapeutics, Inc. (CLDI) stock price, news, quote and history - Yahoo Finance UK

Calidi Biotherapeutics To Carry Out 1-for-16 Reverse Stock Split On July 31st, 2026 - Moomoo

Calidi Gains on Company Update - Baystreet.ca

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers - The Manila Times

Calidi Biotherapeutics to Effect 1-for-16 Reverse Stock Split - marketscreener.com

Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CLDI